Effect of U50,488H, a κ-opioid receptor agonist on myocardial α-and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat

Molecular and Cellular Biochemistry

Volumn 345, Issue 1-2, 2010, Pages 231-240

  Jaiswal, Amardeep ^a   Kumar, Santosh ^a,b   Seth, Sandeep ^a   Dinda, Amit Kumar ^a   Maulik, Subir Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Echocardiography; Fibrosis; Myocyte size; U50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; CATALASE; GLUTATHIONE; ISOPRENALINE; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROSIS; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; LIPID PEROXIDATION; MALE; MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; CARDIOMEGALY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; ISOPROTERENOL; LIPID PEROXIDATION; MALE; MYOSIN HEAVY CHAINS; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; VENTRICULAR MYOSINS;

RATTUS; RATTUS NORVEGICUS;

EID: 78449306063     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0577-4     Document Type: Article

References (67)

1. D Levy RJ Garrison DD Savage WB Kannel WP Castelli 1990 Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study N Engl J Med 322 1561 1566 10.1056/NEJM199005313222203 2139921
2. AK Dhalla MF Hill PK Singal 1996 Role of oxidative stress in transition of hypertrophy to heart failure J Am Coll Cardiol 28 506 514 10.1016/0735-1097(96)00140-4 8800132
3. R Pick JS Janicki KT Weber 1989 Myocardial fibrosis in nonhuman primate with pressure overload hypertrophy Am J Pathol 135 771 781 2530905
4. MP Gupta 2007 Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure J Mol Cell Cardiol 43 388 403 10.1016/j.yjmcc. 2007.07.045 17720186
5. M Krenz A Sanbe F Bouyer-Dalloz J Gulick R Klevitsky TE Hewett HE Osinska JN Lorenz C Brosseau A Federico NR Alpert DM Warshaw MB Perryman SM Helmke J Robbins 2003 Analysis of myosin heavy chain functionality in the heart J Biol Chem 278 17466 17474 10.1074/jbc.M210804200 12626511
6. M Krenz J Robbins 2004 Impact of beta-myosin heavy chain expression on cardiac function during stress J Am Coll Cardiol 44 2390 2397 10.1016/j.jacc.2004.09.044 15607403
7. JC Tardiff TE Hewett SM Factor KL Vikstrom J Robbins LA Leinwand 2000 Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects Am J Physiol Heart Circ Physiol 278 H412 H419 10666070
8. J James L Martin M Krenz C Quatman F Jones R Klevitsky J Gulick J Robbins 2005 Forced expression of -myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions Circulation 111 2339 2346 10.1161/01.CIR.0000164233.09448.B1 15867177
9. PH Sugden A Clerk 1998 Cellular mechanisms of cardiac hypertrophy J Mol Med 76 725 746 10.1007/s001090050275 9826118
10. DB Sawyer DA Siwik L Xiao DR Pimentel K Singh WS Colucci 2002 Role of oxidative stress in myocardial hypertrophy and failure J Mol Cell Cardiol 34 379 388 10.1006/jmcc.2002.1526 11991728
11. DJ Chess W Xu R Khairallah KM O'Shea WJ Kop AM Azimzadeh WC Stanley 2008 The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet Am J Physiol Heart Circ Physiol 295 H2223 H2230 10.1152/ajpheart.00563.2008 18931030
12. NS Dhalla RM Temsah T Netticadan 2000 Role of oxidative stress in cardiovascular diseases J Hypertens 18 655 673 10.1097/00004872-200018060-00002 10872549
13. C Ventura L Bastagli P Bernardi CM Caldarera C Guarnieri 1989 Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol Biochim Biophys Acta 987 69 74 10.1016/0005-2736(89)90456-2 2557082
14. G Wu H Wang J Yang Y Yang C Liu L Jing TM Wong 2008 kappa-Opioid receptor stimulation inhibits augmentation of Ca(2 +) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes-role of CaMKIIdelta(B) Eur J Pharmacol 595 52 57 10.1016/j.ejphar.2008.07.059 18721804
15. W Yin P Zhang JH Huang QY Zhang R Fan J Li JJ Zhou YZ Hu HT Guo SM Zhang YM Wang AD Kaye CH Gu JC Liu L Cheng Q Cui DH Yi JM Pei 2009 Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis Eur J Pharmacol 607 135 142 10.1016/j.ejphar.2009.01.050 19233160
16. GD Arthur AN Belcastro 1997 A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy Mol Cell Biochem 176 241 248 10.1023/A:1006857213829 9406168
17. MK Pugsley WP Penz MJ Walker TM Wong 1992 Cardiovascular actions of the kappa-agonist, U-50, 488H, in the absence and presence of opioid receptor blockade Br J Pharmacol 105 521 526 1320979
18. M Sumitra P Manikandan KV Rao M Nayeem BM Manohar R Puvanakrishnan 2004 Cardiorespiratory effects of diazepam-ketamine, xylazine-ketamine and thiopentone anesthesia in male Wistar rats-a comparative analysis Life Sci 75 1887 1896 15302232
19. S Kumar S Seth A Jaiswal R Enjamoori AK Dinda R Ray SK Maulik 2009 Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats Pharmacol Rep 61 870 876 19904010
20. RM Lang M Bierig RB Devereux FA Flachskampf E Foster PA Pellikka MH Picard MJ Roman J Seward JS Shanewise SD Solomon KT Spencer MS Sutton WJ Stewart 2005 Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 1440 1463 10.1016/j.echo.2005.10.005 16376782
21. SE Litwin SE Katz JP Morgan PS Douglas 1994 Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat Circulation 89 345 354 8281668
22. AJ Woodiwiss OJ Tsotetsi S Sprott EJ Lancaster T Mela ES Chung TE Meyer GR Norton 2001 Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction Circulation 103 155 160 11136701
23. H Okhawa N Oohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 351 358 10.1016/0003-2697(79)90738-3
24. GL Ellman 1959 Tissue sulphydryl groups Arch Biochem Biophy 82 70 77 10.1016/0003-9861(59)90090-6
25. P Kakkar B Das PN Viswanathan 1984 A modified spectrophotometric assay of superoxide dismutase Ind J Biochem Biophys 21 130 132
26. Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Chemic Academic Press Inc., Verlag, pp 673-685
27. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 942051
28. M Chiariello G Ambrosio M Cappelli-Bigazzi P Perrone-Filardi F Brigante C Sifola 1986 A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion J Mol Cell Cardiol 18 283 290 10.1016/S0022-2828(86)80410-2 3083110
29. GX Zhang S Kimura A Nishiyama T Shokoji M Rahman L Yao Y Nagai Y Fujisawa A Miyatake Y Abe 2005 Cardiac oxidative stress in acute and chronic isoproterenol-infused rats Cardiovasc Res 65 230 238 10.1016/j.cardiores.2004. 08.013 15621051
30. G Iaccarino PC Dolber RJ Lefkowitz WJ Koch 1999 Bbeta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation Hypertension 33 396 401 9931136
31. R Pick JE Jalil JS Janicki KT Weber 1989 The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat Am J Pathol 134 365 371 2916652
32. IJ Benjamin JE Jalil LB Tan K Cho KT Weber WA Clark 1989 Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis Circ Res 65 657 670 2527639
33. S Kumar S Sood R Enjamoori A Jaiswal AK Dinda TS Roy SK Maulik 2009 Method for enhanced separation of cardiac myosin heavy chain isoforms by nongradient SDS-PAGE Anal Lett 42 2311 2318
34. L Vennila KV Pugalendi 2010 Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats Redox Rep 15 36 42 10.1179/174329210X12650506623168 20196927
35. S Kumar R Enjamoori A Jaiswal R Ray S Seth SK Maulik 2009 Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.) J Pharm Pharmacol 61 1529 1536 19903379
36. MK Gupta TV Neelakantan M Sanghamitra RK Tyagi A Dinda S Maulik CK Mukhopadhyay SK Goswami 2006 An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts Antioxid Redox Signal 8 1081 1093 10.1089/ars.2006.8. 1081 16771697
37. DA Siwik PJ Pagano WS Colucci 2001 Oxidative stress regulates collagen synthesis and matrix etalloproteinase activity in cardiac fibroblasts Am J Physiol Cell Physiol 280 C53 C60 11121376
38. D Sorescu KK Griendling 2002 Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure Congest Heart Fail 8 132 140 10.1111/j.1527-5299.2002.00717.x 12045381
39. W Grossman D Jones LP McLaurin 1975 Wall stress and patterns of hypertrophy in the human left ventricle J Clin Invest 56 56 64 10.1172/JCI108079 124746
40. OE Osadchii 2007 Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects Heart Fail Rev 12 66 86 10.1007/s10741-007-9007-4 17387610
41. SE Litwin SE Katz EO Weinberg BH Lorell GP Aurigemma PS Douglas 1995 Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure Circulation 91 2642 2654 7743628
42. N Saadane L Alpert LE Chalifour 1999 Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice Br J Pharmacol 127 1165 1176 10.1038/sj.bjp.0702676 10455263
43. B Nadal-Ginard V Mahdavi 1989 Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoforms switches J Clin Invest 84 1693 1700 10.1172/JCI114351 2687327
44. WK Jones IL Grupp T Doetschman G Grupp H Osinska TE Hewett G Boivin J Gulick WA Ng J Robbins J Robbins 1996 Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart J Clin Invest 98 1906 1907 10.1172/JCI118992 8878443
45. DE Harris SS Work RK Wright NR Alpert DM Warshaw 1994 Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro J Muscle Res Cell Motil 15 11 19 10.1007/BF00123828 8182105
46. C Holubarsch RP Goulette RZ Litten BJ Martin LA Mulieri NR Alpert 1985 The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium Circ Res 56 78 86 3155672
47. S Sugiura N Kobayakawa H Fujita H Yamashita S Momomura S Chaen M Omata H Sugi 1998 Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation Circ Res 82 1029 1034 9622155
48. WT Abraham EM Gilbert BD Lowes WA Minobe P Larrabee RL Roden D Dutcher J Sederberg JA Lindenfeld EE Wolfel SF Shakar D Ferguson K Volkman JV Linseman RA Quaife AD Robertson MR Bristow 2002 Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype Mol Med 8 750 760 12520092
49. KT Weber 2000 Fibrosis and hypertensive heart disease Curr Opin Cardiol 15 264 272 10.1097/00001573-200007000-00010 11139090
50. KT Weber CG Brilla JS Janicki 1993 Myocardial fibrosis: functional significance and regulatory factors Cardiovasc Res 27 341 348 10.1093/cvr/27.3.341 8490934
51. C Cuspidi M Ciulla A Zanchetti 2006 Hypertensive myocardial fibrosis Nephrol Dial Transplant 21 20 23 10.1093/ndt/gfi237 16263734
52. P Assayag F Carré B Chevalier C Delcayre P Mansier B Swynghedauw 1997 Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype I. Fibrosis. Cardiovasc Res 34 439 444
53. K Pandya HS Kim O Smithies 2006 Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo Proc Natl Acad Sci USA 103 16864 16869 10.1073/pnas.0607700103 17068123
54. JS Bian HX Wang WM Zhang TM Wong 1998 Effects of κ-opioid receptor stimulation in the heart and the involvement of protein kinase C Br J Pharmacol 124 600 606 10.1038/sj.bjp.0701857 9647487
55. C Morisco DC Zebrowski DE Vatner SF Vatner J Sadoshima 2001 β-Adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heart J Mol Cell Cardiol 33 561 573 10.1006/jmcc.2000.1332 11181023
56. JZ Sheng NS Wong HX Wang TM Wong 1997 Pertussis toxin, but not tyrosine kinase inhibitors, abolishes effects of U-50488H on [Ca2+]i in myocytes Am J Physiol 272 C560 C564 9124299
57. JM Pei YM Wang YL Zhu M Chen TM Wong 2001 Signaling pathway mediated by κ-opioid receptor is impaired in cardiac hypertrophy Acta Pharmacol Sin 22 887 895 11749770
58. S Pepe OW Van den Brink EG Lakatta RP Xiao 2004 Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart Cardiovasc Res 63 414 422 10.1016/j.cardiores.2004.04.022 15276466
59. D Shan H Wang Y Su Y Jing TM Wong 2007 κ-opioid receptor stimulation inhibits cardiac hypertrophy induced by β1-adrenoceptor stimulation in the rat Eur J Pharmacol 555 100 105 10.1016/j.ejphar.2006.10.040 17126321
60. XC Yu TM Diao JM Pei WM Zhang NS Wong TM Wong 2001 Kappa-opioid receptor agonist inhibits the cholera toxin-sensitive G protein in the heart J Cardiovasc Pharmacol 38 232 239 10.1097/00005344-200108000-00009 11483873
61. BA Jordan N Trapaidze I Gomes R Nivarthi LA Devi 2001 Oligomerization of opioid receptors with β2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation Proc Natl Acad Sci U S A 98 343 348 10.1073/pnas.011384898 11134510
62. S Pepe RP Xiao C Hohl R Altschuld EG Lakatta 1997 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart Circulation 95 2122 2129 9133523
63. PS Portoghese MM Lunzer 2003 Identity of the putative δ1-opioid receptor as a δ-κ heteromer in the mouse spinal cord Eur J Pharmacol 467 233 234 10.1016/S0014-2999(03)01599-1 12706480
64. G Wang H Wang Y Yang TM Wong 2004 Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes Eur J Pharmacol 13 53 58 10.1016/j.ejphar.2004.07.082
65. J Shan XC Yu ML Fung TM Wong 2002 Attenuated "cross talk" between κ-opioid receptors and beta-adrenoceptors in the heart of chronically hypoxic rats Pflügers Arch 444 126 132 10.1007/s00424-002-0814- 0 11976924
66. XC Yu HY Li HX Wang TM Wong 1998 U50, 488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors J Mol Cell Cardiol 30 405 413 10.1006/jmcc.1997.0604 9515017
67. PJ McLaughlin 1994 Opioid antagonist modulation of rat heart development Life Sci 54 1423 1431 10.1016/0024-3205(94)00597-4 8190015